An okadaic acid-induced model of tauopathy and cognitive deficiency

[1]  J. Simpkins,et al.  Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable manner , 2010, Brain Research.

[2]  G Forster,et al.  Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. , 2009, Brain : a journal of neurology.

[3]  D. Praticò,et al.  Evidence of Oxidative Stress in Alzheimer's Disease Brain and Antioxidant Therapy , 2008, Annals of the New York Academy of Sciences.

[4]  M. Glicksman,et al.  Kinetic studies of Cdk5/p25 kinase: phosphorylation of tau and complex inhibition by two prototype inhibitors. , 2008, Biochemistry.

[5]  M. Asashima,et al.  Neural Stem Cells Improve Learning and Memory in Rats with Alzheimer’s Disease , 2008, Pathobiology.

[6]  Hyoung-Gon Lee,et al.  Alzheimer Disease Pathology As a Host Response , 2008, Journal of neuropathology and experimental neurology.

[7]  D. Dias-Santagata,et al.  Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. , 2007, Molecular biology of the cell.

[8]  Yee‐Shin Lin,et al.  GSK-3β acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis , 2007, Journal of Cell Science.

[9]  A. Sakamoto,et al.  Cognitive decline in temporal lobe epilepsy due to unilateral hippocampal sclerosis , 2007, Epilepsy & Behavior.

[10]  George Perry,et al.  Alzheimer disease, the two-hit hypothesis: an update. , 2007, Biochimica et biophysica acta.

[11]  Xiongwei Zhu,et al.  Involvement of Oxidative Stress in Alzheimer Disease , 2006, Journal of neuropathology and experimental neurology.

[12]  J. Simpkins,et al.  Novel Mechanisms for Estrogen-Induced Neuroprotection , 2006, Experimental biology and medicine.

[13]  I. Grundke‐Iqbal,et al.  Dysregulation of Protein Phosphorylation/Dephosphorylation in Alzheimer's Disease: A Therapeutic Target , 2006, Journal of biomedicine & biotechnology.

[14]  Fei Liu,et al.  Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation , 2005, The European journal of neuroscience.

[15]  K. Duff,et al.  Untangling memory deficits , 2005, Nature Medicine.

[16]  Haiyun Xu,et al.  Olanzapine Attenuates the Okadaic Acid-Induced Spatial Memory Impairment and Hippocampal Cell Death in Rats , 2005, Neuropsychopharmacology.

[17]  B. Hyman,et al.  Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.

[18]  J. Ávila,et al.  Estradiol Prevents Neural Tau Hyperphosphorylation Characteristic of Alzheimer's Disease , 2005, Annals of the New York Academy of Sciences.

[19]  N. Shahani,et al.  Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. , 2005, Biochimica et biophysica acta.

[20]  G. Johnson,et al.  Tau phosphorylation in neuronal cell function and dysfunction , 2004, Journal of Cell Science.

[21]  J. Simpkins,et al.  Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein , 2004, Brain Research.

[22]  P. Barbier,et al.  Tau Induces Ring and Microtubule Formation from R‚-Tubulin Dimers under Nonassembly Conditions † , 2004 .

[23]  J. Simpkins,et al.  Transient Cerebral Ischemia Induces Aberrant Neuronal Cell Cycle Re-entry and Alzheimer's Disease-like Tauopathy in Female Rats* , 2004, Journal of Biological Chemistry.

[24]  Xiongwei Zhu,et al.  Alzheimer's disease: the two-hit hypothesis , 2004, The Lancet Neurology.

[25]  G. Johnson,et al.  Cyclin‐dependent kinase‐5 in neurodegeneration , 2004, Journal of neurochemistry.

[26]  Jesus Avila,et al.  Role of tau protein in both physiological and pathological conditions. , 2004, Physiological reviews.

[27]  R. Liu,et al.  Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats , 2003, Neuroscience.

[28]  Ramona O Hopkins,et al.  Semantic Memory and the Human Hippocampus , 2003, Neuron.

[29]  Joseph R. Manns,et al.  Recognition Memory and the Human Hippocampus , 2003, Neuron.

[30]  J. E. Leonard,et al.  Disruption of estrogen receptor β gene impairs spatial learning in female mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Simon Lovestone,et al.  Alzheimer's disease – do tauists and baptists finally shake hands? , 2002, Trends in Neurosciences.

[32]  R. Jope,et al.  The multifaceted roles of glycogen synthase kinase 3β in cellular signaling , 2001, Progress in Neurobiology.

[33]  S. Fujita,et al.  Inhibition of Protein Phosphatase 2A Overrides Tau Protein Kinase I/Glycogen Synthase Kinase 3β and Cyclin-dependent Kinase 5 Inhibition and Results in Tau Hyperphosphorylation in the Hippocampus of Starved Mouse* , 2001, The Journal of Biological Chemistry.

[34]  René Hen,et al.  Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice , 2001 .

[35]  M. Smith,et al.  Oxidative stress in Alzheimer's disease. , 2000, Biochimica et biophysica acta.

[36]  R. D. Williams,et al.  Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  L. Tsai,et al.  Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration , 1999, Nature.

[38]  Kinzo Matsumoto,et al.  Different effects of unilateral and bilateral hippocampal lesions in rats on the performance of radial maze and odor-paired associate tasks , 1999, Brain Research Bulletin.

[39]  W. Markesbery,et al.  Oxidative Alterations in Alzheimer's Disease , 1999, Brain pathology.

[40]  L. Nadel,et al.  Spatial memory deficits in patients with lesions to the right hippocampus and to the right parahippocampal cortex , 1998, Neuropsychologia.

[41]  T. Arendt,et al.  The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer's disease , 1998, Neuroscience.

[42]  T. Arendt,et al.  Phosphorylation of Tau, Aβ-Formation, and Apoptosis After In Vivo Inhibition of PP-1 and PP-2A , 1998, Neurobiology of Aging.

[43]  S. Lovestone,et al.  The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. , 1997, Neuroscience.

[44]  Mark A. Smith,et al.  4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.

[45]  M. Billingsley,et al.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. , 1997, The Biochemical journal.

[46]  A. Pickering,et al.  Spatial memory deficits in patients with unilateral damage to the right hippocampal formation , 1997, Neuropsychologia.

[47]  R. Morris,et al.  Spatial learning with a minislab in the dorsal hippocampus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[48]  E. Vanmechelen,et al.  Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 , 1995, Neuroscience Letters.

[49]  K. Titani,et al.  Proline-directed and Non-proline-directed Phosphorylation of PHF-tau (*) , 1995, The Journal of Biological Chemistry.

[50]  K. Imahori,et al.  Precursor of cdk5 activator, the 23 kDa subunit of tau protein kinase II: Its sequence and developmental change in brain , 1994, FEBS letters.

[51]  L. Tsai,et al.  p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 , 1994, Nature.

[52]  I. Grundke‐Iqbal,et al.  Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A , 1994, Neuroscience.

[53]  I. Grundke‐Iqbal,et al.  Dephosphorylation of microtubule‐associated protein tau by protein phosphatase‐1 and ‐2C and its implication in Alzheimer disease , 1994, FEBS letters.

[54]  I. Grundke‐Iqbal,et al.  Alzheimer's Disease Abnormally Phosphorylated τ Is Dephosphorylated by Protein Phosphatase‐2B (Calcineurin) , 1994, Journal of neurochemistry.

[55]  J. H. Wang,et al.  Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. , 1993, The Journal of biological chemistry.

[56]  P. Andersen,et al.  Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[57]  K. Imahori,et al.  Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments , 1993 .

[58]  J. Woodgett,et al.  Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase , 1992, Neuroscience Letters.

[59]  J. Ávila,et al.  Microtubule-associated protein tau is phosphorylated by protein kinase C on its tubulin binding domain. , 1992, The Journal of biological chemistry.

[60]  G. Drewes,et al.  Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state. , 1992, The EMBO journal.

[61]  Bradley T. Hyman,et al.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.

[62]  L. Nadel.  The hippocampus and space revisited , 1991, Hippocampus.

[63]  J. Woodgett,et al.  Molecular cloning and expression of glycogen synthase kinase‐3/factor A. , 1990, The EMBO journal.

[64]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.

[65]  J. Baudier,et al.  Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. , 1987, The Journal of biological chemistry.

[66]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[67]  H. Wiśniewski,et al.  Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.

[68]  M. Kirschner,et al.  A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[69]  P. Barbier,et al.  Tau induces ring and microtubule formation from alphabeta-tubulin dimers under nonassembly conditions. , 2004, Biochemistry.

[70]  R. Hen,et al.  Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. , 2001, The EMBO journal.

[71]  C. Filley.  Alzheimer's disease in women. , 1997, American journal of obstetrics and gynecology.

[72]  A. Smith,et al.  Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. , 1995, Dementia.

[73]  K. Imahori,et al.  Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. , 1993, FEBS letters.